Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Current Leases (2020 - 2025)

Historic Current Leases for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • Tango Therapeutics' Current Leases rose 834.79% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 834.79%. This contributed to the annual value of $2.5 million for FY2024, which is 1786.74% up from last year.
  • As of Q3 2025, Tango Therapeutics' Current Leases stood at $3.1 million, which was up 834.79% from $2.5 million recorded in Q2 2025.
  • Tango Therapeutics' Current Leases' 5-year high stood at $3.1 million during Q3 2025, with a 5-year trough of $629000.0 in Q2 2022.
  • For the 5-year period, Tango Therapeutics' Current Leases averaged around $2.0 million, with its median value being $2.1 million (2024).
  • In the last 5 years, Tango Therapeutics' Current Leases tumbled by 2847.99% in 2022 and then soared by 18728.14% in 2023.
  • Over the past 5 years, Tango Therapeutics' Current Leases (Quarter) stood at $1.5 million in 2021, then grew by 17.76% to $1.8 million in 2022, then grew by 17.63% to $2.1 million in 2023, then rose by 17.87% to $2.5 million in 2024, then rose by 26.41% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.5 million for Q2 2025, and $2.8 million during Q1 2025.